Abstract
Vestibular schwannoma (VS) represents a challenging intracranial tumor to treat. Almost a century ago, the most prominent neurosurgeons in Europe reported operative mortality rates greater than 70% [1–3]. Harvey Cushing, in the US, advocated for a wide bilateral posterior fossa decompression and intracapsular internal decompression of the tumor to achieve a safe subtotal resection (STR) and reduced the operative mortality to ~20% [4, 5]. Walter Dandy, on the other hand, described a unilateral craniectomy and complete tumor removal with the necessary sacrifice of cranial nerves VII and VIII but obviating the risk of tumor regrowth and need for additional treatment [6–9]. Over the next several decades, the integration of the operating microscope, improvement in neuroanesthetic techniques, and development of intraoperative electromyographic (EMG) monitoring have markedly improved the outcome from microsurgical resection of VS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ballance SCA. Some points in the surgery of the brain and its membranes. London: Macmillan; 1908.
Koerbel A, Gharabaghi A, Safavi-Abbasi S, Tatagiba M, Samii M. Evolution of vestibular schwannoma surgery: the long journey to current success. Neurosurg Focus. 2005;18:e10.
Krause F. Discussion of von Eiselsberg’s paper. Tr Int Cong Med Lond VII. 1913;214.
Cushing H. Tumors of the nervus acusticus and the syndrome of the cerebellopontile angle. Philadelphia: W.B. Saunders; 1917.
Cushing H. Further concerning the acoustic neuromas. Laryngoscope. 1921;31:209–28.
Dandy WE. An operation for the total extirpation of tumors in the cerebello-pontine angle. A preliminary report. Bull Johns Hopkins Hosp. 1922;33:344–5.
Dandy WE, Others. An operation for the total removal of cerebellopontine (acoustic) tumors. Surg Gynecol Obstet. 1925;41:129–48.
Dandy WE. Removal of cerebellopontile (acoustic) tumors through a unilateral approach. Arch Surg. 1934;29:337–44.
Dandy WE. Results of removal of acoustic tumors by the unilateral approach. Arch Surg. 1941;42:1026–33.
Leksell L. A note on the treatment of acoustic tumours. Acta Chir Scand. 1971;137:763–5.
Flickinger JC, Lunsford LD, Linskey ME, Duma CM, Kondziolka D. Gamma knife radiosurgery for acoustic tumors: multivariate analysis of four year results. Radiother Oncol. 1993;27:91–8.
Smouha EE, Yoo M, Mohr K, Davis RP. Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm. Laryngoscope. 2005;115:450–4.
Yoshimoto Y. Systematic review of the natural history of vestibular schwannoma. J Neurosurg. 2005;103:59–63.
Hajioff D, Raut VV, Walsh RM, et al. Conservative management of vestibular schwannomas: third review of a 10-year prospective study. Clin Otolaryngol. 2008;33:255–9.
Malhotra PS, Sharma P, Fishman MA, et al. Clinical, radiographic, and audiometric predictors in conservative management of vestibular schwannoma. Otol Neurotol. 2009;30:507–14.
Hoistad DL, Melnik G, Mamikoglu B, Battista R, O’Connor CA, Wiet RJ. Update on conservative management of acoustic neuroma. Otol Neurotol. 2001;22:682–5.
Shin YJ, Fraysse B, Cognard C, et al. Effectiveness of conservative management of acoustic neuromas. Am J Otol. 2000;21:857–62.
Stangerup S-E, Caye-Thomasen P. Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin N Am. 2012;45:257–68.
Pullicino R, Radon M, Biswas S, Bhojak M, Das K. A review of the current evidence on gadolinium deposition in the brain. Clin Neuroradiol. 2018;28:159–69. https://doi.org/10.1007/s00062-018-0678-0.
Olson JJ, Kalkanis SN, Ryken TC. Congress of neurological surgeons systematic review and evidence-based guidelines on the treatment of adults with vestibular schwannomas: executive summary. Neurosurgery. 2018;82:129–34.
Van Gompel JJ, Patel J, Danner C, et al. Acoustic neuroma observation associated with an increase in symptomatic tinnitus: results of the 2007–2008 Acoustic Neuroma Association survey. Collections. 2013;118:864–8.
Stangerup S-E, Thomsen J, Tos M, Cayé-Thomasen P. Long-term hearing preservation in vestibular schwannoma. Otol Neurotol. 2010;31:271–5.
Balkany TA, Gates GA, Goldenberg RA, et al. Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). Otolaryngol Head Neck Surg. 1995;113:179–80.
Kirchmann M, Karnov K, Hansen S, Dethloff T, Stangerup S-E, Caye-Thomasen P. Ten-year follow-up on tumor growth and hearing in patients observed with an intracanalicular vestibular schwannoma. Neurosurgery. 2017;80:49–56.
Flint D, Fagan P, Panarese A. Conservative management of sporadic unilateral acoustic neuromas. J Laryngol Otol. 2005;119:424–8.
Telian SA. Management of the small acoustic neuroma: a decision analysis. Am J Otol. 1994;15:358–65.
Murphy ES, Suh JH. Radiotherapy for vestibular schwannomas: a critical review. Int J Radiat Oncol Biol Phys. 2011;79:985–97.
Link MJ, Driscoll CLW, Foote RL, Pollock BE. Radiation therapy and radiosurgery for vestibular schwannomas: indications, techniques, and results. Otolaryngol Clin N Am. 2012;45:353–66.
Kondziolka D, Lunsford LD, McLaughlin MR, Flickinger JC. Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med. 1998;339:1426–33.
Chopra R, Kondziolka D, Niranjan A, Lunsford LD, Flickinger JC. Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys. 2007;68:845–51.
Hasegawa T, Fujitani S, Katsumata S, Kida Y, Yoshimoto M, Koike J. Stereotactic radiosurgery for vestibular schwannomas: analysis of 317 patients followed more than 5 years. Neurosurgery. 2005;57:257–65.
Pollock BE, Lunsford LD, Kondziolka D, et al. Outcome analysis of acoustic neuroma management: a comparison of microsurgery and stereotactic radiosurgery. Neurosurgery. 1995;36:215–24.
Friedman RA, Kesser B, Brackmann DE, Fisher LM, Slattery WH, Hitselberger WE. Long-term hearing preservation after middle fossa removal of vestibular schwannoma. Otolaryngol Head Neck Surg. 2003;129:660–5.
Régis J, Pellet W, Delsanti C, et al. Functional outcome after gamma knife surgery or microsurgery for vestibular schwannomas. J Neurosurg. 2013;119:1091–100.
Yang I, Sughrue ME, Han SJ, et al. A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. J Neurosurg. 2010;112:851–9.
Kano H, Kondziolka D, Khan A, Flickinger JC, Lunsford LD. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma. J Neurosurg. 2009;111:863–73.
Hasegawa T, Kida Y, Kato T, Iizuka H, Yamamoto T. Factors associated with hearing preservation after Gamma Knife surgery for vestibular schwannomas in patients who retain serviceable hearing. J Neurosurg. 2011;115:1078–86.
Hasegawa T, Kida Y, Kato T, Iizuka H, Kuramitsu S, Yamamoto T. Long-term safety and efficacy of stereotactic radiosurgery for vestibular schwannomas: evaluation of 440 patients more than 10 years after treatment with Gamma Knife surgery. J Neurosurg. 2013;118:557–65.
Carlson ML, Jacob JT, Pollock BE, et al. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline. J Neurosurg. 2013;118:579–87.
Williams BJ, Xu Z, Salvetti DJ, McNeill IT, Larner J, Sheehan JP. Gamma Knife surgery for large vestibular schwannomas: a single-center retrospective case-matched comparison assessing the effect of lesion size. J Neurosurg. 2013;119:463–71.
Chan AW, Black P, Ojemann RG, et al. Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity. Neurosurgery. 2005;57:60–70.
Wise SC, Carlson ML, Tveiten ØV, et al. Surgical salvage of recurrent vestibular schwannoma following prior stereotactic radiosurgery. Laryngoscope. 2016;126:2580–6.
Coughlin AR, Willman TJ, Gubbels SP. Systematic review of hearing preservation after radiotherapy for vestibular schwannoma. Otol Neurotol. 2018;39:273–83.
Hasegawa T, Kida Y, Kobayashi T, Yoshimoto M, Mori Y, Yoshida J. Long-term outcomes in patients with vestibular schwannomas treated using gamma knife surgery: 10-year follow up. J Neurosurg. 2005;102:10–6.
Jacob JT, Pollock BE, Carlson ML, Driscoll CLW, Link MJ. Stereotactic radiosurgery in the management of vestibular schwannoma and glomus jugulare: indications, techniques, and results. Otolaryngol Clin N Am. 2015;48:515–26.
Jacob JT, Carlson ML, Schiefer TK, Pollock BE, Driscoll CL, Link MJ. Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions. Neurosurgery. 2014;74:466–74.
Massager N, Nissim O, Delbrouck C, et al. Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome. J Neurosurg. 2007;107:733–9.
Friedman WA, Bradshaw P, Myers A, Bova FJ. Linear accelerator radiosurgery for vestibular schwannomas. J Neurosurg. 2006;105:657–61.
Foote KD, Friedman WA, Buatti JM, Meeks SL, Bova FJ, Kubilis PS. Analysis of risk factors associated with radiosurgery for vestibular schwannoma. J Neurosurg. 2001;95:440–9.
Spiegelmann R, Lidar Z, Gofman J, Alezra D, Hadani M, Pfeffer R. Linear accelerator radiosurgery for vestibular schwannoma. J Neurosurg. 2001;94:7–13.
Combs SE, Thilmann C, Debus J, Schulz-Ertner D. Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas. Int J Radiat Oncol Biol Phys. 2006;64:1341–7.
Fukuoka S, Takanashi M, Hojyo A, Konishi M, Tanaka C, Nakamura H. Gamma knife radiosurgery for vestibular schwannomas. Prog Neurol Surg. 2009;22:45–62.
Iwai Y, Yamanaka K, Kubo T, Aiba T. Gamma knife radiosurgery for intracanalicular acoustic neuromas. J Clin Neurosci. 2008;15:993–7.
Kalogeridi M-A, Georgolopoulou P, Kouloulias V, Kouvaris J, Pissakas G. Long-term results of LINAC-based stereotactic radiosurgery for acoustic neuroma: the Greek experience. J Cancer Res Ther. 2009;5:8–13.
Kim K-M, Park C-K, Chung H-T, Paek SH, Jung H-W, Kim DG. Long-term outcomes of gamma knife stereotactic radiosurgery of vestibular schwannomas. J Korean Neurosurg Soc. 2007;42:286–92.
Myrseth E, Moller P, Pedersen P-H, Vassbotn FS, Wentzel-Larsen T, Lund-Johansen M. Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery. 2005;56:927–35.
Prasad D, Steiner M, Steiner L. Gamma surgery for vestibular schwannoma. J Neurosurg. 2000;92:745–59.
Unger F, Walch C, Schröttner O, Eustacchio S, Sutter B, Pendl G. Cranial nerve preservation after radiosurgery of vestibular schwannomas. Acta Neurochir Suppl. 2002;84:77–83.
Linskey ME, Flickinger JC, Lunsford LD. Cranial nerve length predicts the risk of delayed facial and trigeminal neuropathies after acoustic tumor stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 1993;25:227–33.
Combs SE, Welzel T, Schulz-Ertner D, Huber PE, Debus J. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys. 2010;76:193–200.
Murphy ES, Barnett GH, Vogelbaum MA, et al. Long-term outcomes of Gamma Knife radiosurgery in patients with vestibular schwannomas. J Neurosurg. 2011;114:432–40.
Wallner KE, Sheline GE, Pitts LH, Wara WM, Davis RL, Boldrey EB. Efficacy of irradiation for incompletely excised acoustic neurilemomas. J Neurosurg. 1987;67:858–63.
Maire J-P, Huchet A, Milbeo Y, et al. Twenty years’ experience in the treatment of acoustic neuromas with fractionated radiotherapy: a review of 45 cases. Int J Radiat Oncol Biol Phys. 2006;66:170–8.
Fuss M, Debus J, Lohr F, et al. Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas. Int J Radiat Oncol Biol Phys. 2000;48:1381–7.
Meijer OWM, Vandertop WP, Baayen JC, Slotman BJ. Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study. Int J Radiat Oncol Biol Phys. 2003;56:1390–6.
Selch MT, Pedroso A, Lee SP, et al. Stereotactic radiotherapy for the treatment of acoustic neuromas. J Neurosurg. 2004;101:362–72.
Combs SE, Volk S, Schulz-Ertner D, Huber PE, Thilmann C, Debus J. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution. Int J Radiat Oncol Biol Phys. 2005;63:75–81.
Kalapurakal JA, Silverman CL, Akhtar N, Andrews DW, Downes B, Thomas PR. Improved trigeminal and facial nerve tolerance following fractionated stereotactic radiotherapy for large acoustic neuromas. Br J Radiol. 1999;72:1202–7.
Andrews DW, Werner-Wasik M, Den RB, et al. Toward dose optimization for fractionated stereotactic radiotherapy for acoustic neuromas: comparison of two dose cohorts. Int J Radiat Oncol Biol Phys. 2009;74:419–26.
Koh E-S, Millar B-A, Menard C, et al. Fractionated stereotactic radiotherapy for vestibular schwannoma: single institutional experience at the Princess Margaret Hospital. Radiother Oncol. 2005;76:S29.
Thomas C, Di Maio S, Ma R, et al. Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose. J Neurosurg. 2007;107:917–26.
Jian BJ, Kaur G, Sayegh ET, Bloch O, Parsa AT, Barani IJ. Fractionated radiation therapy for vestibular schwannoma. J Clin Neurosci. 2014;21:1083–8.
Litre F, Rousseaux P, Jovenin N, et al. Fractionated stereotactic radiotherapy for acoustic neuromas: a prospective monocenter study of about 158 cases. Radiother Oncol. 2013;106:169–74.
Aoyama H, Onodera S, Takeichi N, et al. Symptomatic outcomes in relation to tumor expansion after fractionated stereotactic radiation therapy for vestibular schwannomas: single-institutional long-term experience. Int J Radiat Oncol Biol Phys. 2013;85:329–34.
Nguyen T, Duong C, Sheppard JP, et al. Hypo-fractionated stereotactic radiotherapy of five fractions with linear accelerator for vestibular schwannomas: a systematic review and meta-analysis. Clin Neurol Neurosurg. 2018;166:116–23.
Andrews DW, Suarez O, Goldman HW, et al. Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys. 2001;50:1265–78.
Bush DA, Mcallister CJ, Loredo LN, Johnson WD, Slater JM, Slater JD. Fractionated proton beam radiotherapy for acoustic neuroma. Neurosurgery. 2002;50:270–5.
Harsh GR, Thornton AF, Chapman PH, Bussiere MR, Rabinov JD, Loeffler JS. Proton beam stereotactic radiosurgery of vestibular schwannomas. Int J Radiat Oncol Biol Phys. 2002;54:35–44.
Vernimmen FJAI, Mohamed Z, Slabbert JP, Wilson J. Long-term results of stereotactic proton beam radiotherapy for acoustic neuromas. Radiother Oncol. 2009;90:208–12.
Weber DC, Chan AW, Bussiere MR, et al. Proton beam radiosurgery for vestibular schwannoma: tumor control and cranial nerve toxicity. Neurosurgery. 2003;53:577–88.
Tanbouzi Husseini S, Piccirillo E, Taibah A, Paties CT, Rizzoli R, Sanna M. Malignancy in vestibular schwannoma after stereotactic radiotherapy: a case report and review of the literature. Laryngoscope. 2011;121:923–8.
Fusco DJ, Williamson R, Yanamadala V, Eschbacher J, Porter R, Weisskopf P. Malignant transformation of a vestibular schwannoma following gamma knife radiosurgery: case report and review of the literature. J Neurol Surg B Skull Base. 2012;73:A293.
Niranjan A, Kondziolka D, Lunsford LD. Neoplastic transformation after radiosurgery or radiotherapy: risk and realities. Otolaryngol Clin N Am. 2009;42:717–29.
Kondziolka D, Mousavi SH, Kano H, Flickinger JC, Lunsford LD. The newly diagnosed vestibular schwannoma: radiosurgery, resection, or observation? Neurosurg Focus. 2012;33:E8.
Wiet RJ, Mamikoglu B, Odom L, Hoistad DL. Long-term results of the first 500 cases of acoustic neuroma surgery. Otolaryngol Head Neck Surg. 2001;124:645–51.
Sanna M, Taibah A, Russo A, Falcioni M, Agarwal M. Perioperative complications in acoustic neuroma (vestibular schwannoma) surgery. Otol Neurotol. 2004;25:379–86.
Bambakidis NC, Megerian CA, Spetzler RF. Surgery of the cerebellopontine angle. Shelton, CT: PMPH-USA; 2009.
Ramsden RT. A brilliant surgical result, the first recorded: Annandale’s case, 3 May 1895. J Laryngol Otol. 1995;109:369–73.
Olson JJ, Kalkanis SN, Ryken TC. Congress of neurological surgeons systematic review and evidence-based guidelines on the treatment of adults with vestibular schwannomas: introduction and methods. Neurosurgery. 2018;82:135.
Parry RH. A case of tinnitus and vertigo treated by division of the auditory nerve. J Laryngol Otol. 1904;19:402–6.
Quix FH. Ein Fall von translabyrintharisch operiertem Tumor acusticus. Verh Dtsch Otol Ges. 1912;21:245–55.
House WF. Transtemporal bone microsurgical removal of acoustic neuromas. Report of cases. Arch Otolaryngol. 1964;80:617–67.
Dandy WE, et al. An operation for the total removal of cerebellopontine (acoustic) tumors. Surg Gynecol Obstet. 1925;41:129–48.
Dandy WE. Removal of cerebellontine (acoustic) tumors through a unilateral approach. Arch Surg. 1934;29:337–44.
Gonzalez LF, Lekovic GP, Porter RW, Syms MJ, Daspit CP, Spetzler RF. Surgical approaches for resection of acoustic neuromas. Barrow Q. 2004;20:1–11.
Day JD, Chen DA, Arriaga M. Translabyrinthine approach for acoustic neuroma. Neurosurgery. 2004;54:391–6.
Nakatomi H, Jacob JT, Carlson ML, et al. Long-term risk of recurrence and regrowth after gross-total and subtotal resection of sporadic vestibular schwannoma. J Neurosurg. 2017;19:1–7.
Jacob JT, Carlson ML, Driscoll CL, Link MJ. Volumetric analysis of tumor control following subtotal and near-total resection of vestibular schwannoma. Laryngoscope. 2016;126:1877–82.
Yamakami I, Uchino Y, Kobayashi E, Yamaura A. Conservative management, gamma-knife radiosurgery, and microsurgery for acoustic neurinomas: a systematic review of outcome and risk of three therapeutic options. Neurol Res. 2003;25:682–90.
Monfared A, Corrales CE, Theodosopoulos PV, et al. Facial nerve outcome and tumor control rate as a function of degree of resection in treatment of large acoustic neuromas: preliminary report of the acoustic neuroma subtotal resection study (ANSRS). Neurosurgery. 2016;79:194–203.
Mangham CA Jr. Retrosigmoid versus middle fossa surgery for small vestibular schwannomas. Laryngoscope. 2004;114:1455–61.
Sanna M, Khrais T, Russo A, Piccirillo E, Augurio A. Hearing preservation surgery in vestibular schwannoma: the hidden truth. Ann Otol Rhinol Laryngol. 2004;113:156–63.
Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): hearing function in 1000 tumor resections. Neurosurgery. 1997;40:248–62.
McElveen JT Jr, Belmonte RG, Fukushima T, Bullard DE. A review of facial nerve outcome in 100 consecutive cases of acoustic tumor surgery. Laryngoscope. 2000;110:1667–72.
Colletti V, Fiorino F. Middle fossa versus retrosigmoid-transmeatal approach in vestibular schwannoma surgery: a prospective study. Otol Neurotol. 2003;24:927–34.
Arts HA, Telian SA, El-Kashlan H, Thompson BG. Hearing preservation and facial nerve outcomes in vestibular schwannoma surgery: results using the middle cranial fossa approach. Otol Neurotol. 2006;27:234–41.
Fenton JE, Chin RY, Fagan PA, Sterkers O, Sterkers JM. Predictive factors of long-term facial nerve function after vestibular schwannoma surgery. Otol Neurotol. 2002;23:388–92.
Lanman TH, Brackmann DE, Hitselberger WE, Subin B. Report of 190 consecutive cases of large acoustic tumors (vestibular schwannoma) removed via the translabyrinthine approach. J Neurosurg. 1999;90:617–23.
Hadjipanayis CG, Carlson ML, Link MJ, et al. Congress of neurological surgeons systematic review and evidence-based guidelines on surgical resection for the treatment of patients with vestibular schwannomas. Neurosurgery. 2018;82:E40–3.
Copeland WR, Mallory GW, Neff BA, Driscoll CLW, Link MJ. Are there modifiable risk factors to prevent a cerebrospinal fluid leak following vestibular schwannoma surgery? J Neurosurg. 2015;122:312–6.
Murphy ME, McCutcheon BA, Kerezoudis P, et al. Morbid obesity increases risk of morbidity and reoperation in resection of benign cranial nerve neoplasms. Clin Neurol Neurosurg. 2016;148:105–9.
Selesnick SH, Liu JC, Jen A, Carew JF. Management options for cerebrospinal fluid leak after vestibular schwannoma surgery and introduction of an innovative treatment. Otol Neurotol. 2004;25:580–6.
Alattar AA, Hirshman BR, McCutcheon BA, et al. Risk factors for readmission with cerebrospinal fluid leakage within 30 d of vestibular schwannoma surgery. Neurosurgery. 2018;82:630–7. https://doi.org/10.1093/neuros/nyx197.
Isaacson JE. Radiologic follow-up after vestibular schwannoma surgery. Otol Neurotol. 2005;26:552.
Costantino PD, Hiltzik DH, Sen C, et al. Sphenoethmoid cerebrospinal fluid leak repair with hydroxyapatite cement. Arch Otolaryngol Head Neck Surg. 2001;127:588–93.
Gauden A, Weir P, Hawthorne G, Kaye A. Systematic review of quality of life in the management of vestibular schwannoma. J Clin Neurosci. 2011;18:1573–84.
Gouveris HT, Mann WJ. Quality of life in sporadic vestibular schwannoma: a review. ORL J Otorhinolaryngol Relat Spec. 2010;72:69–74.
Martin HC, Sethi J, Lang D, Neil-Dwyer G, Lutman ME, Yardley L. Patient-assessed outcomes after excision of acoustic neuroma: postoperative symptoms and quality of life. J Neurosurg. 2001;94:211–6.
Nicoucar K, Momjian S, Vader J-P, De Tribolet N. Surgery for large vestibular schwannomas: how patients and surgeons perceive quality of life. J Neurosurg. 2006;105:205–12.
Shaffer BT, Cohen MS, Bigelow DC, Ruckenstein MJ. Validation of a disease-specific quality-of-life instrument for acoustic neuroma: the Penn Acoustic Neuroma Quality-of-Life Scale. Laryngoscope. 2010;120:1646–54.
Di Maio S, Akagami R. Prospective comparison of quality of life before and after observation, radiation, or surgery for vestibular schwannomas. J Neurosurg. 2009;111:855–62.
Breivik CN, Varughese JK, Wentzel-Larsen T, Vassbotn F, Lund-Johansen M. Conservative management of vestibular schwannoma—a prospective cohort study: treatment, symptoms, and quality of life. Neurosurgery. 2012;70:1072–80.
Myrseth E, Møller P, Pedersen P-H, Lund-Johansen M. Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery. 2009;64:654–63.
Pollock BE, Driscoll CLW, Foote RL, et al. Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery. 2006;59:77–85.
Carlson ML, Tveiten OV, Driscoll CL, Goplen FK. Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery. J Neurosurg. 2015;122:833–42.
Soulier G, van Leeuwen BM, Putter H, et al. Quality of life in 807 patients with vestibular schwannoma: comparing treatment modalities. Otolaryngol Head Neck Surg. 2017;157:92–8.
Link MJ, Lund-Johansen M, Lohse CM, et al. Quality of life in patients with vestibular schwannomas following gross total or less than gross total microsurgical resection: should we be taking the entire tumor out? Neurosurgery. 2018;82:541–7.
Carlson ML, Tveiten ØV, Yost KJ, Lohse CM, Lund-Johansen M, Link MJ. The minimal clinically important difference in vestibular schwannoma quality-of-life assessment: an important step beyond P < .05. Otolaryngol Head Neck Surg. 2015;153:202–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kerezoudis, P., Weisskopf, P.A., Driscoll, C.L.W., Link, M.J. (2022). Treatment Options for Acoustic Neuroma, Including Stereotactic Radiosurgery. In: Bambakidis, N.C., Megerian, C.A., Spetzler, R.F. (eds) Surgery of the Cerebellopontine Angle. Springer, Cham. https://doi.org/10.1007/978-3-031-12507-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-031-12507-2_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-12506-5
Online ISBN: 978-3-031-12507-2
eBook Packages: MedicineMedicine (R0)